Full-Time
Sales Representative
Updated on 9/3/2026
Inizio
5,001-10,000 employees
Guides clinical development and commercialization
No salary listed
Indianapolis, IN, USA + 1 more
More locations: Des Moines, IA, USA
In Person
Field-based role requiring travel within assigned territories.
 Sales & Account Management (1) |
|---|
Get referred to Inizio
See people who can refer or advise you
- Proven sales experience (pharmaceutical or healthcare preferred)
- Strong communication and presentation skills
- Demonstrated ability to build relationships and drive results
- Self-motivated with strong organizational skills
- Ability to manage a territory effectively and travel as required
- Build and maintain strong professional relationships with healthcare providers
- Educate customers on approved products in accordance with regulatory and compliance guidelines
- Develop and execute strategic territory business plans
- Analyze territory data to identify growth opportunities
- Drive performance through ethical, customer-focused engagement
Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.
Company Size
5,001-10,000
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
N/A
Get referred to Inizio
See people who can refer or advise you
Simplify's Take
What believers are saying
- Inizio launched Connected Insights on July 28, 2026, expanding APAC medical-information services.
- On May 12, 2026, Intelligent Congress added measurable analytics to a high-spend commercial offering.
- Hub Services launched April 23, 2026, strengthening patient access, reimbursement, and adherence programs.
What critics are saying
- The 2025 annual report showed a $16.7 million restructuring charge and workforce streamlining.
- Headcount fell from 10,872 in 2023 to 10,004 by March 2026.
- Big pharma clients can consolidate vendors or insource services, crushing Inizio's outsourced margin base.
What makes Inizio unique
- Inizio serves 100% of top 20 pharma across 50 countries and 175 congresses yearly.
- Its integrated model spans medical affairs, congresses, patient access, and commercialization execution.
- Inizio embeds AI across workflows, from voice analytics to virtual agents and training personas.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Performance Bonus
Professional Development Budget
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 5%1 year growth
↑ 5%2 year growth
↑ 7%Inizio has expanded its Global Medical Information capabilities through Inizio Engage, launching Connected Insights to help pharmaceutical and biotechnology companies transform medical information into strategic intelligence. The service combines expanded Asia-Pacific expertise, enhanced global infrastructure, and AI-enabled innovation. The company supports more than one million medical information interactions annually across 500+ products in 55+ global programmes, delivering services in over 20 languages. AI-powered features have increased training simulations tenfold and improved training success by 50%. The expansion includes continued growth across the APAC region, expanded global infrastructure, and AI-enabled innovations throughout the medical information workflow, including AI-powered training personas, speech analytics, and virtual agents. The investment reinforces Inizio's commitment to connecting scientific expertise with technology and data-driven insight across the product lifecycle.
Inizio, a global commercialisation partner to health and life sciences companies, has launched Intelligent Congress, an end-to-end solution designed to maximise the value of medical congress investments and deliver measurable business impact. The platform addresses fragmented planning and unclear objectives that often dilute congress opportunities. It integrates strategy, experience design, delivery and measurement across the full congress lifecycle, enabling clients to focus on meaningful shifts in healthcare professional engagement and behaviour rather than isolated metrics. Intelligent Congress uses a four-step framework spanning the entire congress calendar, capturing real-time insights and evaluating impact against key datasets. Inizio has supported over 80 clients across 27 countries, facilitating more than 1,000 healthcare professional engagements and managing over 25,500 attendees.
Inizio has launched its fully integrated Hub Services through its Inizio Engage business unit, targeting improved patient access, reimbursement and adherence for life sciences companies. The solution combines advanced analytics, pharmacy capabilities and specialised expertise to streamline the patient journey. The offering includes non-dispensing pharmacy services for benefit verification and fulfilment coordination, comprehensive access and reimbursement support, field reimbursement services and non-commercial dispensing pharmacy. Advanced analytics predict potential delays before they occur. Inizio Engage, which employs over 6,000 experts across 20 countries and delivers over 5 million engagements annually, will showcase the service at the Asembia Summit in Las Vegas from 27–30 April 2026. The company has made significant investments in leadership across patient access, pharmacy, reimbursement and analytics to support the service.
LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization
Inizio Medical, the leading provider of Medical Affairs and communications solutions, today announced the appointment of Patrick Giordani as Senior Vice President, AI Solutions Architect.